nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimozide—CYP3A7—Ifosfamide—testicular cancer	0.104	0.143	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.104	0.143	CbGbCtD
Pimozide—CYP3A5—Ifosfamide—testicular cancer	0.0783	0.108	CbGbCtD
Pimozide—CYP2C19—Ifosfamide—testicular cancer	0.0632	0.0867	CbGbCtD
Pimozide—CYP2E1—Etoposide—testicular cancer	0.0482	0.0661	CbGbCtD
Pimozide—ABCB1—Dactinomycin—testicular cancer	0.0432	0.0593	CbGbCtD
Pimozide—CYP3A5—Etoposide—testicular cancer	0.0374	0.0514	CbGbCtD
Pimozide—CYP3A4—Ifosfamide—testicular cancer	0.0306	0.0419	CbGbCtD
Pimozide—CYP1A2—Etoposide—testicular cancer	0.0279	0.0382	CbGbCtD
Pimozide—ABCB1—Vinblastine—testicular cancer	0.027	0.0371	CbGbCtD
Pimozide—CYP2D6—Vinblastine—testicular cancer	0.0255	0.035	CbGbCtD
Pimozide—ABCB1—Cisplatin—testicular cancer	0.0248	0.034	CbGbCtD
Pimozide—ABCB1—Etoposide—testicular cancer	0.0244	0.0334	CbGbCtD
Pimozide—ABCB1—Doxorubicin—testicular cancer	0.0166	0.0228	CbGbCtD
Pimozide—CYP3A4—Vinblastine—testicular cancer	0.0162	0.0222	CbGbCtD
Pimozide—ABCB1—Methotrexate—testicular cancer	0.0161	0.0221	CbGbCtD
Pimozide—CYP2D6—Doxorubicin—testicular cancer	0.0157	0.0215	CbGbCtD
Pimozide—CYP3A4—Etoposide—testicular cancer	0.0146	0.02	CbGbCtD
Pimozide—CYP3A4—Doxorubicin—testicular cancer	0.00996	0.0137	CbGbCtD
Pimozide—CALM2—semen—testicular cancer	0.0083	0.142	CbGeAlD
Pimozide—CALM1—semen—testicular cancer	0.00827	0.141	CbGeAlD
Pimozide—HTR2A—vein—testicular cancer	0.00601	0.103	CbGeAlD
Pimozide—CALM3—seminal vesicle—testicular cancer	0.00224	0.0383	CbGeAlD
Pimozide—CALM2—embryo—testicular cancer	0.00187	0.032	CbGeAlD
Pimozide—CALM1—embryo—testicular cancer	0.00187	0.0319	CbGeAlD
Pimozide—CALM2—seminal vesicle—testicular cancer	0.00176	0.0301	CbGeAlD
Pimozide—KCNH2—seminal vesicle—testicular cancer	0.00159	0.0272	CbGeAlD
Pimozide—CALM3—female gonad—testicular cancer	0.00132	0.0225	CbGeAlD
Pimozide—CALM2—gonad—testicular cancer	0.00127	0.0217	CbGeAlD
Pimozide—CALM1—gonad—testicular cancer	0.00127	0.0216	CbGeAlD
Pimozide—OPRM1—testis—testicular cancer	0.00126	0.0216	CbGeAlD
Pimozide—CYP2E1—seminal vesicle—testicular cancer	0.00123	0.021	CbGeAlD
Pimozide—CALM3—testis—testicular cancer	0.00117	0.0199	CbGeAlD
Pimozide—HTR2A—embryo—testicular cancer	0.00114	0.0194	CbGeAlD
Pimozide—CALM2—female gonad—testicular cancer	0.00103	0.0177	CbGeAlD
Pimozide—CALM1—female gonad—testicular cancer	0.00103	0.0176	CbGeAlD
Pimozide—KCNH2—female gonad—testicular cancer	0.000937	0.016	CbGeAlD
Pimozide—CALM2—testis—testicular cancer	0.000917	0.0157	CbGeAlD
Pimozide—CALM1—testis—testicular cancer	0.000913	0.0156	CbGeAlD
Pimozide—CALM3—lymph node—testicular cancer	0.000846	0.0145	CbGeAlD
Pimozide—DRD2—testis—testicular cancer	0.000843	0.0144	CbGeAlD
Pimozide—KCNH2—testis—testicular cancer	0.000831	0.0142	CbGeAlD
Pimozide—CYP3A5—female gonad—testicular cancer	0.000773	0.0132	CbGeAlD
Pimozide—HTR2A—gonad—testicular cancer	0.000771	0.0132	CbGeAlD
Pimozide—HRH1—female gonad—testicular cancer	0.000751	0.0128	CbGeAlD
Pimozide—ABCB1—embryo—testicular cancer	0.000745	0.0127	CbGeAlD
Pimozide—ABCB1—seminal vesicle—testicular cancer	0.0007	0.0119	CbGeAlD
Pimozide—HRH1—testis—testicular cancer	0.000666	0.0114	CbGeAlD
Pimozide—CALM2—lymph node—testicular cancer	0.000665	0.0114	CbGeAlD
Pimozide—CALM1—lymph node—testicular cancer	0.000662	0.0113	CbGeAlD
Pimozide—CYP2E1—testis—testicular cancer	0.00064	0.0109	CbGeAlD
Pimozide—KCNH2—lymph node—testicular cancer	0.000602	0.0103	CbGeAlD
Pimozide—Myalgia—Ifosfamide—testicular cancer	0.000576	0.003	CcSEcCtD
Pimozide—Chest pain—Ifosfamide—testicular cancer	0.000576	0.003	CcSEcCtD
Pimozide—Anorexia—Dactinomycin—testicular cancer	0.000574	0.00299	CcSEcCtD
Pimozide—Eye disorder—Etoposide—testicular cancer	0.000573	0.00298	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.000572	0.00298	CcSEcCtD
Pimozide—CYP2D6—female gonad—testicular cancer	0.000571	0.00976	CbGeAlD
Pimozide—Diarrhoea—Chlorambucil—testicular cancer	0.000571	0.00297	CcSEcCtD
Pimozide—Cardiac disorder—Etoposide—testicular cancer	0.000569	0.00296	CcSEcCtD
Pimozide—Decreased appetite—Bleomycin—testicular cancer	0.000561	0.00292	CcSEcCtD
Pimozide—Visual disturbance—Methotrexate—testicular cancer	0.00056	0.00292	CcSEcCtD
Pimozide—Muscle spasms—Cisplatin—testicular cancer	0.00056	0.00292	CcSEcCtD
Pimozide—HTR2A—testis—testicular cancer	0.000556	0.0095	CbGeAlD
Pimozide—Vision blurred—Cisplatin—testicular cancer	0.000549	0.00286	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.000549	0.00286	CcSEcCtD
Pimozide—Asthenia—Vinblastine—testicular cancer	0.000548	0.00285	CcSEcCtD
Pimozide—Tremor—Cisplatin—testicular cancer	0.000546	0.00284	CcSEcCtD
Pimozide—Nervous system disorder—Ifosfamide—testicular cancer	0.000541	0.00282	CcSEcCtD
Pimozide—Anaemia—Cisplatin—testicular cancer	0.000539	0.0028	CcSEcCtD
Pimozide—Skin disorder—Ifosfamide—testicular cancer	0.000536	0.00279	CcSEcCtD
Pimozide—Hyperhidrosis—Ifosfamide—testicular cancer	0.000533	0.00278	CcSEcCtD
Pimozide—Vomiting—Chlorambucil—testicular cancer	0.00053	0.00276	CcSEcCtD
Pimozide—Increased appetite—Epirubicin—testicular cancer	0.000529	0.00275	CcSEcCtD
Pimozide—Anorexia—Ifosfamide—testicular cancer	0.000526	0.00274	CcSEcCtD
Pimozide—Decreased appetite—Dactinomycin—testicular cancer	0.000523	0.00272	CcSEcCtD
Pimozide—Diarrhoea—Vinblastine—testicular cancer	0.000523	0.00272	CcSEcCtD
Pimozide—Leukopenia—Cisplatin—testicular cancer	0.000522	0.00272	CcSEcCtD
Pimozide—Hypotension—Ifosfamide—testicular cancer	0.000516	0.00268	CcSEcCtD
Pimozide—Muscle spasms—Etoposide—testicular cancer	0.000513	0.00267	CcSEcCtD
Pimozide—Urticaria—Bleomycin—testicular cancer	0.000513	0.00267	CcSEcCtD
Pimozide—CYP2D6—testis—testicular cancer	0.000507	0.00865	CbGeAlD
Pimozide—ABCB1—gonad—testicular cancer	0.000506	0.00864	CbGeAlD
Pimozide—Dizziness—Vinblastine—testicular cancer	0.000505	0.00263	CcSEcCtD
Pimozide—Convulsion—Cisplatin—testicular cancer	0.000505	0.00263	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.000503	0.00262	CcSEcCtD
Pimozide—Hyponatraemia—Epirubicin—testicular cancer	0.000499	0.0026	CcSEcCtD
Pimozide—Myalgia—Cisplatin—testicular cancer	0.000496	0.00258	CcSEcCtD
Pimozide—Nausea—Chlorambucil—testicular cancer	0.000495	0.00258	CcSEcCtD
Pimozide—Anaemia—Etoposide—testicular cancer	0.000494	0.00257	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.000493	0.00256	CcSEcCtD
Pimozide—Somnolence—Ifosfamide—testicular cancer	0.000491	0.00255	CcSEcCtD
Pimozide—Increased appetite—Doxorubicin—testicular cancer	0.000489	0.00255	CcSEcCtD
Pimozide—Vomiting—Vinblastine—testicular cancer	0.000486	0.00253	CcSEcCtD
Pimozide—HRH1—lymph node—testicular cancer	0.000483	0.00824	CbGeAlD
Pimozide—Breast disorder—Methotrexate—testicular cancer	0.00048	0.0025	CcSEcCtD
Pimozide—Decreased appetite—Ifosfamide—testicular cancer	0.00048	0.0025	CcSEcCtD
Pimozide—Headache—Vinblastine—testicular cancer	0.000479	0.00249	CcSEcCtD
Pimozide—Leukopenia—Etoposide—testicular cancer	0.000478	0.00249	CcSEcCtD
Pimozide—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000476	0.00248	CcSEcCtD
Pimozide—Constipation—Ifosfamide—testicular cancer	0.000472	0.00246	CcSEcCtD
Pimozide—Loss of consciousness—Etoposide—testicular cancer	0.000469	0.00244	CcSEcCtD
Pimozide—Nervous system disorder—Cisplatin—testicular cancer	0.000466	0.00243	CcSEcCtD
Pimozide—Tachycardia—Cisplatin—testicular cancer	0.000464	0.00242	CcSEcCtD
Pimozide—Asthenia—Bleomycin—testicular cancer	0.000463	0.00241	CcSEcCtD
Pimozide—Convulsion—Etoposide—testicular cancer	0.000463	0.00241	CcSEcCtD
Pimozide—Skin disorder—Cisplatin—testicular cancer	0.000462	0.0024	CcSEcCtD
Pimozide—Hyponatraemia—Doxorubicin—testicular cancer	0.000462	0.0024	CcSEcCtD
Pimozide—Hypertension—Etoposide—testicular cancer	0.000461	0.0024	CcSEcCtD
Pimozide—Hyperhidrosis—Cisplatin—testicular cancer	0.00046	0.00239	CcSEcCtD
Pimozide—Pruritus—Bleomycin—testicular cancer	0.000457	0.00238	CcSEcCtD
Pimozide—Chest pain—Etoposide—testicular cancer	0.000455	0.00237	CcSEcCtD
Pimozide—Eosinophilia—Methotrexate—testicular cancer	0.000454	0.00237	CcSEcCtD
Pimozide—Nausea—Vinblastine—testicular cancer	0.000454	0.00236	CcSEcCtD
Pimozide—Orthostatic hypotension—Epirubicin—testicular cancer	0.000454	0.00236	CcSEcCtD
Pimozide—Anorexia—Cisplatin—testicular cancer	0.000453	0.00236	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000451	0.00235	CcSEcCtD
Pimozide—Breast disorder—Epirubicin—testicular cancer	0.000449	0.00234	CcSEcCtD
Pimozide—Hypotension—Cisplatin—testicular cancer	0.000444	0.00231	CcSEcCtD
Pimozide—Abdominal discomfort—Methotrexate—testicular cancer	0.00044	0.00229	CcSEcCtD
Pimozide—Urticaria—Ifosfamide—testicular cancer	0.000438	0.00228	CcSEcCtD
Pimozide—Pancytopenia—Methotrexate—testicular cancer	0.000436	0.00227	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000433	0.00226	CcSEcCtD
Pimozide—Asthenia—Dactinomycin—testicular cancer	0.000432	0.00225	CcSEcCtD
Pimozide—Dysphagia—Epirubicin—testicular cancer	0.00043	0.00224	CcSEcCtD
Pimozide—Tachycardia—Etoposide—testicular cancer	0.000425	0.00221	CcSEcCtD
Pimozide—Eosinophilia—Epirubicin—testicular cancer	0.000425	0.00221	CcSEcCtD
Pimozide—Skin disorder—Etoposide—testicular cancer	0.000423	0.0022	CcSEcCtD
Pimozide—Erectile dysfunction—Methotrexate—testicular cancer	0.000423	0.0022	CcSEcCtD
Pimozide—Hyperhidrosis—Etoposide—testicular cancer	0.000421	0.00219	CcSEcCtD
Pimozide—Orthostatic hypotension—Doxorubicin—testicular cancer	0.00042	0.00219	CcSEcCtD
Pimozide—Breast disorder—Doxorubicin—testicular cancer	0.000416	0.00216	CcSEcCtD
Pimozide—Anorexia—Etoposide—testicular cancer	0.000415	0.00216	CcSEcCtD
Pimozide—Decreased appetite—Cisplatin—testicular cancer	0.000413	0.00215	CcSEcCtD
Pimozide—Diarrhoea—Dactinomycin—testicular cancer	0.000412	0.00214	CcSEcCtD
Pimozide—ABCB1—female gonad—testicular cancer	0.000411	0.00702	CbGeAlD
Pimozide—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000411	0.00214	CcSEcCtD
Pimozide—Vomiting—Bleomycin—testicular cancer	0.00041	0.00214	CcSEcCtD
Pimozide—Drowsiness—Methotrexate—testicular cancer	0.000409	0.00213	CcSEcCtD
Pimozide—Depression—Methotrexate—testicular cancer	0.000408	0.00212	CcSEcCtD
Pimozide—Pancytopenia—Epirubicin—testicular cancer	0.000408	0.00212	CcSEcCtD
Pimozide—Hypotension—Etoposide—testicular cancer	0.000407	0.00212	CcSEcCtD
Pimozide—Rash—Bleomycin—testicular cancer	0.000407	0.00212	CcSEcCtD
Pimozide—Dermatitis—Bleomycin—testicular cancer	0.000407	0.00212	CcSEcCtD
Pimozide—Dysphagia—Doxorubicin—testicular cancer	0.000397	0.00207	CcSEcCtD
Pimozide—Pollakiuria—Epirubicin—testicular cancer	0.000397	0.00207	CcSEcCtD
Pimozide—Asthenia—Ifosfamide—testicular cancer	0.000396	0.00206	CcSEcCtD
Pimozide—Eosinophilia—Doxorubicin—testicular cancer	0.000394	0.00205	CcSEcCtD
Pimozide—Sweating—Methotrexate—testicular cancer	0.000392	0.00204	CcSEcCtD
Pimozide—Weight increased—Epirubicin—testicular cancer	0.000391	0.00203	CcSEcCtD
Pimozide—Pruritus—Ifosfamide—testicular cancer	0.00039	0.00203	CcSEcCtD
Pimozide—Weight decreased—Epirubicin—testicular cancer	0.000389	0.00202	CcSEcCtD
Pimozide—Somnolence—Etoposide—testicular cancer	0.000387	0.00202	CcSEcCtD
Pimozide—Nausea—Bleomycin—testicular cancer	0.000383	0.002	CcSEcCtD
Pimozide—Drowsiness—Epirubicin—testicular cancer	0.000383	0.00199	CcSEcCtD
Pimozide—Vomiting—Dactinomycin—testicular cancer	0.000383	0.00199	CcSEcCtD
Pimozide—Agranulocytosis—Methotrexate—testicular cancer	0.000382	0.00199	CcSEcCtD
Pimozide—Rash—Dactinomycin—testicular cancer	0.00038	0.00198	CcSEcCtD
Pimozide—Decreased appetite—Etoposide—testicular cancer	0.000379	0.00197	CcSEcCtD
Pimozide—Diarrhoea—Ifosfamide—testicular cancer	0.000378	0.00196	CcSEcCtD
Pimozide—Pancytopenia—Doxorubicin—testicular cancer	0.000377	0.00196	CcSEcCtD
Pimozide—Gastrointestinal disorder—Etoposide—testicular cancer	0.000376	0.00196	CcSEcCtD
Pimozide—Constipation—Etoposide—testicular cancer	0.000373	0.00194	CcSEcCtD
Pimozide—Sweating—Epirubicin—testicular cancer	0.000367	0.00191	CcSEcCtD
Pimozide—Pollakiuria—Doxorubicin—testicular cancer	0.000367	0.00191	CcSEcCtD
Pimozide—Dizziness—Ifosfamide—testicular cancer	0.000365	0.0019	CcSEcCtD
Pimozide—ABCB1—testis—testicular cancer	0.000364	0.00622	CbGeAlD
Pimozide—Weight increased—Doxorubicin—testicular cancer	0.000362	0.00188	CcSEcCtD
Pimozide—Weight decreased—Doxorubicin—testicular cancer	0.00036	0.00187	CcSEcCtD
Pimozide—Nausea—Dactinomycin—testicular cancer	0.000358	0.00186	CcSEcCtD
Pimozide—Agranulocytosis—Epirubicin—testicular cancer	0.000357	0.00186	CcSEcCtD
Pimozide—Drowsiness—Doxorubicin—testicular cancer	0.000354	0.00184	CcSEcCtD
Pimozide—Visual impairment—Methotrexate—testicular cancer	0.000354	0.00184	CcSEcCtD
Pimozide—Vomiting—Ifosfamide—testicular cancer	0.000351	0.00183	CcSEcCtD
Pimozide—Rash—Ifosfamide—testicular cancer	0.000348	0.00181	CcSEcCtD
Pimozide—Dermatitis—Ifosfamide—testicular cancer	0.000348	0.00181	CcSEcCtD
Pimozide—Urticaria—Etoposide—testicular cancer	0.000346	0.0018	CcSEcCtD
Pimozide—Eye disorder—Methotrexate—testicular cancer	0.000343	0.00179	CcSEcCtD
Pimozide—Asthenia—Cisplatin—testicular cancer	0.000341	0.00178	CcSEcCtD
Pimozide—Cardiac disorder—Methotrexate—testicular cancer	0.000341	0.00177	CcSEcCtD
Pimozide—Sweating—Doxorubicin—testicular cancer	0.00034	0.00177	CcSEcCtD
Pimozide—Connective tissue disorder—Epirubicin—testicular cancer	0.000338	0.00176	CcSEcCtD
Pimozide—Visual impairment—Epirubicin—testicular cancer	0.000331	0.00172	CcSEcCtD
Pimozide—Agranulocytosis—Doxorubicin—testicular cancer	0.000331	0.00172	CcSEcCtD
Pimozide—Nausea—Ifosfamide—testicular cancer	0.000328	0.00171	CcSEcCtD
Pimozide—Diarrhoea—Cisplatin—testicular cancer	0.000325	0.00169	CcSEcCtD
Pimozide—Mental disorder—Methotrexate—testicular cancer	0.000322	0.00168	CcSEcCtD
Pimozide—Eye disorder—Epirubicin—testicular cancer	0.000321	0.00167	CcSEcCtD
Pimozide—Cardiac disorder—Epirubicin—testicular cancer	0.000319	0.00166	CcSEcCtD
Pimozide—Asthenia—Etoposide—testicular cancer	0.000313	0.00163	CcSEcCtD
Pimozide—Connective tissue disorder—Doxorubicin—testicular cancer	0.000313	0.00163	CcSEcCtD
Pimozide—Pruritus—Etoposide—testicular cancer	0.000308	0.0016	CcSEcCtD
Pimozide—Visual impairment—Doxorubicin—testicular cancer	0.000307	0.0016	CcSEcCtD
Pimozide—Vomiting—Cisplatin—testicular cancer	0.000302	0.00157	CcSEcCtD
Pimozide—Vision blurred—Methotrexate—testicular cancer	0.000301	0.00157	CcSEcCtD
Pimozide—Mental disorder—Epirubicin—testicular cancer	0.000301	0.00157	CcSEcCtD
Pimozide—Rash—Cisplatin—testicular cancer	0.0003	0.00156	CcSEcCtD
Pimozide—Dermatitis—Cisplatin—testicular cancer	0.0003	0.00156	CcSEcCtD
Pimozide—Diarrhoea—Etoposide—testicular cancer	0.000298	0.00155	CcSEcCtD
Pimozide—Eye disorder—Doxorubicin—testicular cancer	0.000297	0.00155	CcSEcCtD
Pimozide—Anaemia—Methotrexate—testicular cancer	0.000296	0.00154	CcSEcCtD
Pimozide—Cardiac disorder—Doxorubicin—testicular cancer	0.000295	0.00154	CcSEcCtD
Pimozide—Dizziness—Etoposide—testicular cancer	0.000288	0.0015	CcSEcCtD
Pimozide—Muscle spasms—Epirubicin—testicular cancer	0.000288	0.0015	CcSEcCtD
Pimozide—Leukopenia—Methotrexate—testicular cancer	0.000286	0.00149	CcSEcCtD
Pimozide—Nausea—Cisplatin—testicular cancer	0.000283	0.00147	CcSEcCtD
Pimozide—Vision blurred—Epirubicin—testicular cancer	0.000282	0.00147	CcSEcCtD
Pimozide—Mental disorder—Doxorubicin—testicular cancer	0.000279	0.00145	CcSEcCtD
Pimozide—Convulsion—Methotrexate—testicular cancer	0.000277	0.00144	CcSEcCtD
Pimozide—Vomiting—Etoposide—testicular cancer	0.000277	0.00144	CcSEcCtD
Pimozide—Anaemia—Epirubicin—testicular cancer	0.000277	0.00144	CcSEcCtD
Pimozide—Agitation—Epirubicin—testicular cancer	0.000275	0.00143	CcSEcCtD
Pimozide—Rash—Etoposide—testicular cancer	0.000275	0.00143	CcSEcCtD
Pimozide—Dermatitis—Etoposide—testicular cancer	0.000275	0.00143	CcSEcCtD
Pimozide—Headache—Etoposide—testicular cancer	0.000273	0.00142	CcSEcCtD
Pimozide—Chest pain—Methotrexate—testicular cancer	0.000272	0.00142	CcSEcCtD
Pimozide—Myalgia—Methotrexate—testicular cancer	0.000272	0.00142	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.00027	0.00141	CcSEcCtD
Pimozide—Syncope—Epirubicin—testicular cancer	0.000268	0.0014	CcSEcCtD
Pimozide—Leukopenia—Epirubicin—testicular cancer	0.000268	0.00139	CcSEcCtD
Pimozide—Muscle spasms—Doxorubicin—testicular cancer	0.000266	0.00139	CcSEcCtD
Pimozide—Palpitations—Epirubicin—testicular cancer	0.000264	0.00138	CcSEcCtD
Pimozide—ABCB1—lymph node—testicular cancer	0.000264	0.00451	CbGeAlD
Pimozide—Loss of consciousness—Epirubicin—testicular cancer	0.000263	0.00137	CcSEcCtD
Pimozide—Vision blurred—Doxorubicin—testicular cancer	0.000261	0.00136	CcSEcCtD
Pimozide—Convulsion—Epirubicin—testicular cancer	0.000259	0.00135	CcSEcCtD
Pimozide—Nausea—Etoposide—testicular cancer	0.000259	0.00135	CcSEcCtD
Pimozide—Hypertension—Epirubicin—testicular cancer	0.000258	0.00135	CcSEcCtD
Pimozide—Nervous system disorder—Methotrexate—testicular cancer	0.000256	0.00133	CcSEcCtD
Pimozide—Anaemia—Doxorubicin—testicular cancer	0.000256	0.00133	CcSEcCtD
Pimozide—Chest pain—Epirubicin—testicular cancer	0.000255	0.00133	CcSEcCtD
Pimozide—Myalgia—Epirubicin—testicular cancer	0.000255	0.00133	CcSEcCtD
Pimozide—Agitation—Doxorubicin—testicular cancer	0.000254	0.00132	CcSEcCtD
Pimozide—Skin disorder—Methotrexate—testicular cancer	0.000254	0.00132	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000253	0.00132	CcSEcCtD
Pimozide—Hyperhidrosis—Methotrexate—testicular cancer	0.000252	0.00131	CcSEcCtD
Pimozide—Dry mouth—Epirubicin—testicular cancer	0.000249	0.0013	CcSEcCtD
Pimozide—Anorexia—Methotrexate—testicular cancer	0.000249	0.0013	CcSEcCtD
Pimozide—Syncope—Doxorubicin—testicular cancer	0.000248	0.00129	CcSEcCtD
Pimozide—Leukopenia—Doxorubicin—testicular cancer	0.000248	0.00129	CcSEcCtD
Pimozide—Palpitations—Doxorubicin—testicular cancer	0.000245	0.00127	CcSEcCtD
Pimozide—Hypotension—Methotrexate—testicular cancer	0.000244	0.00127	CcSEcCtD
Pimozide—Loss of consciousness—Doxorubicin—testicular cancer	0.000243	0.00127	CcSEcCtD
Pimozide—Shock—Epirubicin—testicular cancer	0.00024	0.00125	CcSEcCtD
Pimozide—Convulsion—Doxorubicin—testicular cancer	0.00024	0.00125	CcSEcCtD
Pimozide—Nervous system disorder—Epirubicin—testicular cancer	0.00024	0.00125	CcSEcCtD
Pimozide—Hypertension—Doxorubicin—testicular cancer	0.000239	0.00124	CcSEcCtD
Pimozide—Tachycardia—Epirubicin—testicular cancer	0.000238	0.00124	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000238	0.00124	CcSEcCtD
Pimozide—Skin disorder—Epirubicin—testicular cancer	0.000237	0.00124	CcSEcCtD
Pimozide—Hyperhidrosis—Epirubicin—testicular cancer	0.000236	0.00123	CcSEcCtD
Pimozide—Insomnia—Methotrexate—testicular cancer	0.000236	0.00123	CcSEcCtD
Pimozide—Myalgia—Doxorubicin—testicular cancer	0.000236	0.00123	CcSEcCtD
Pimozide—Chest pain—Doxorubicin—testicular cancer	0.000236	0.00123	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000234	0.00122	CcSEcCtD
Pimozide—Anorexia—Epirubicin—testicular cancer	0.000233	0.00121	CcSEcCtD
Pimozide—Somnolence—Methotrexate—testicular cancer	0.000232	0.00121	CcSEcCtD
Pimozide—Dry mouth—Doxorubicin—testicular cancer	0.000231	0.0012	CcSEcCtD
Pimozide—Hypotension—Epirubicin—testicular cancer	0.000228	0.00119	CcSEcCtD
Pimozide—Decreased appetite—Methotrexate—testicular cancer	0.000227	0.00118	CcSEcCtD
Pimozide—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000225	0.00117	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000223	0.00116	CcSEcCtD
Pimozide—Shock—Doxorubicin—testicular cancer	0.000222	0.00116	CcSEcCtD
Pimozide—Nervous system disorder—Doxorubicin—testicular cancer	0.000222	0.00115	CcSEcCtD
Pimozide—Insomnia—Epirubicin—testicular cancer	0.000221	0.00115	CcSEcCtD
Pimozide—Tachycardia—Doxorubicin—testicular cancer	0.000221	0.00115	CcSEcCtD
Pimozide—Skin disorder—Doxorubicin—testicular cancer	0.00022	0.00114	CcSEcCtD
Pimozide—Hyperhidrosis—Doxorubicin—testicular cancer	0.000219	0.00114	CcSEcCtD
Pimozide—Somnolence—Epirubicin—testicular cancer	0.000217	0.00113	CcSEcCtD
Pimozide—Anorexia—Doxorubicin—testicular cancer	0.000215	0.00112	CcSEcCtD
Pimozide—Decreased appetite—Epirubicin—testicular cancer	0.000212	0.00111	CcSEcCtD
Pimozide—Hypotension—Doxorubicin—testicular cancer	0.000211	0.0011	CcSEcCtD
Pimozide—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000211	0.0011	CcSEcCtD
Pimozide—Constipation—Epirubicin—testicular cancer	0.000209	0.00109	CcSEcCtD
Pimozide—Urticaria—Methotrexate—testicular cancer	0.000207	0.00108	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000206	0.00107	CcSEcCtD
Pimozide—Insomnia—Doxorubicin—testicular cancer	0.000204	0.00106	CcSEcCtD
Pimozide—Somnolence—Doxorubicin—testicular cancer	0.000201	0.00105	CcSEcCtD
Pimozide—Decreased appetite—Doxorubicin—testicular cancer	0.000196	0.00102	CcSEcCtD
Pimozide—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000195	0.00102	CcSEcCtD
Pimozide—Urticaria—Epirubicin—testicular cancer	0.000194	0.00101	CcSEcCtD
Pimozide—Constipation—Doxorubicin—testicular cancer	0.000193	0.00101	CcSEcCtD
Pimozide—Asthenia—Methotrexate—testicular cancer	0.000187	0.000975	CcSEcCtD
Pimozide—Pruritus—Methotrexate—testicular cancer	0.000185	0.000961	CcSEcCtD
Pimozide—Urticaria—Doxorubicin—testicular cancer	0.00018	0.000935	CcSEcCtD
Pimozide—Diarrhoea—Methotrexate—testicular cancer	0.000179	0.00093	CcSEcCtD
Pimozide—Asthenia—Epirubicin—testicular cancer	0.000175	0.000912	CcSEcCtD
Pimozide—Pruritus—Epirubicin—testicular cancer	0.000173	0.0009	CcSEcCtD
Pimozide—Dizziness—Methotrexate—testicular cancer	0.000173	0.000898	CcSEcCtD
Pimozide—Diarrhoea—Epirubicin—testicular cancer	0.000167	0.00087	CcSEcCtD
Pimozide—Vomiting—Methotrexate—testicular cancer	0.000166	0.000864	CcSEcCtD
Pimozide—Rash—Methotrexate—testicular cancer	0.000165	0.000857	CcSEcCtD
Pimozide—Dermatitis—Methotrexate—testicular cancer	0.000164	0.000856	CcSEcCtD
Pimozide—Headache—Methotrexate—testicular cancer	0.000164	0.000851	CcSEcCtD
Pimozide—Asthenia—Doxorubicin—testicular cancer	0.000162	0.000844	CcSEcCtD
Pimozide—Dizziness—Epirubicin—testicular cancer	0.000162	0.000841	CcSEcCtD
Pimozide—Pruritus—Doxorubicin—testicular cancer	0.00016	0.000832	CcSEcCtD
Pimozide—Vomiting—Epirubicin—testicular cancer	0.000155	0.000808	CcSEcCtD
Pimozide—Nausea—Methotrexate—testicular cancer	0.000155	0.000807	CcSEcCtD
Pimozide—Diarrhoea—Doxorubicin—testicular cancer	0.000155	0.000805	CcSEcCtD
Pimozide—Rash—Epirubicin—testicular cancer	0.000154	0.000802	CcSEcCtD
Pimozide—Dermatitis—Epirubicin—testicular cancer	0.000154	0.000801	CcSEcCtD
Pimozide—Headache—Epirubicin—testicular cancer	0.000153	0.000797	CcSEcCtD
Pimozide—Dizziness—Doxorubicin—testicular cancer	0.000149	0.000778	CcSEcCtD
Pimozide—Nausea—Epirubicin—testicular cancer	0.000145	0.000755	CcSEcCtD
Pimozide—Vomiting—Doxorubicin—testicular cancer	0.000144	0.000748	CcSEcCtD
Pimozide—Rash—Doxorubicin—testicular cancer	0.000143	0.000742	CcSEcCtD
Pimozide—Dermatitis—Doxorubicin—testicular cancer	0.000142	0.000741	CcSEcCtD
Pimozide—Headache—Doxorubicin—testicular cancer	0.000142	0.000737	CcSEcCtD
Pimozide—Nausea—Doxorubicin—testicular cancer	0.000134	0.000699	CcSEcCtD
Pimozide—CALM3—B Cell Activation—KITLG—testicular cancer	6e-05	0.00289	CbGpPWpGaD
Pimozide—CYP1A2—Biological oxidations—HPGDS—testicular cancer	5.97e-05	0.00288	CbGpPWpGaD
Pimozide—CALM2—B Cell Activation—KITLG—testicular cancer	5.8e-05	0.0028	CbGpPWpGaD
Pimozide—CALM1—B Cell Activation—KITLG—testicular cancer	5.8e-05	0.0028	CbGpPWpGaD
Pimozide—CALM3—RNF mutants show enhanced WNT signaling and proliferation—H2AFZ—testicular cancer	5.77e-05	0.00278	CbGpPWpGaD
Pimozide—CALM3—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	5.74e-05	0.00277	CbGpPWpGaD
Pimozide—CALM2—RNF mutants show enhanced WNT signaling and proliferation—H2AFZ—testicular cancer	5.59e-05	0.00269	CbGpPWpGaD
Pimozide—CALM1—RNF mutants show enhanced WNT signaling and proliferation—H2AFZ—testicular cancer	5.59e-05	0.00269	CbGpPWpGaD
Pimozide—CALM2—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	5.55e-05	0.00268	CbGpPWpGaD
Pimozide—CALM1—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	5.55e-05	0.00268	CbGpPWpGaD
Pimozide—CALM3—Downstream signaling of activated FGFR—FGFR3—testicular cancer	5.53e-05	0.00267	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—INSL3—testicular cancer	5.45e-05	0.00263	CbGpPWpGaD
Pimozide—CALM3—Signaling by WNT in cancer—H2AFZ—testicular cancer	5.36e-05	0.00259	CbGpPWpGaD
Pimozide—CALM2—Downstream signaling of activated FGFR—FGFR3—testicular cancer	5.35e-05	0.00258	CbGpPWpGaD
Pimozide—CALM1—Downstream signaling of activated FGFR—FGFR3—testicular cancer	5.35e-05	0.00258	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—INSL3—testicular cancer	5.27e-05	0.00254	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—INSL3—testicular cancer	5.27e-05	0.00254	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—INSL3—testicular cancer	5.2e-05	0.00251	CbGpPWpGaD
Pimozide—CALM3—Downstream signal transduction—FGFR3—testicular cancer	5.2e-05	0.00251	CbGpPWpGaD
Pimozide—CALM1—Signaling by WNT in cancer—H2AFZ—testicular cancer	5.19e-05	0.0025	CbGpPWpGaD
Pimozide—CALM2—Signaling by WNT in cancer—H2AFZ—testicular cancer	5.19e-05	0.0025	CbGpPWpGaD
Pimozide—CALM3—Signaling by FGFR—FGFR3—testicular cancer	5.17e-05	0.00249	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—INSL3—testicular cancer	5.15e-05	0.00248	CbGpPWpGaD
Pimozide—CALM3—Signaling by ERBB2—FGFR3—testicular cancer	5.15e-05	0.00248	CbGpPWpGaD
Pimozide—CALM3—DAP12 signaling—FGFR3—testicular cancer	5.12e-05	0.00247	CbGpPWpGaD
Pimozide—CALM3—Downstream signaling of activated FGFR—KIT—testicular cancer	5.08e-05	0.00245	CbGpPWpGaD
Pimozide—CALM2—Downstream signal transduction—FGFR3—testicular cancer	5.03e-05	0.00242	CbGpPWpGaD
Pimozide—CALM1—Downstream signal transduction—FGFR3—testicular cancer	5.03e-05	0.00242	CbGpPWpGaD
Pimozide—CALM1—Signaling by FGFR—FGFR3—testicular cancer	5e-05	0.00241	CbGpPWpGaD
Pimozide—CALM2—Signaling by FGFR—FGFR3—testicular cancer	5e-05	0.00241	CbGpPWpGaD
Pimozide—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	5e-05	0.00241	CbGpPWpGaD
Pimozide—CALM2—Signaling by ERBB2—FGFR3—testicular cancer	4.98e-05	0.0024	CbGpPWpGaD
Pimozide—CALM1—Signaling by ERBB2—FGFR3—testicular cancer	4.98e-05	0.0024	CbGpPWpGaD
Pimozide—CALM2—DAP12 signaling—FGFR3—testicular cancer	4.95e-05	0.00239	CbGpPWpGaD
Pimozide—CALM1—DAP12 signaling—FGFR3—testicular cancer	4.95e-05	0.00239	CbGpPWpGaD
Pimozide—CALM2—Downstream signaling of activated FGFR—KIT—testicular cancer	4.91e-05	0.00237	CbGpPWpGaD
Pimozide—CALM1—Downstream signaling of activated FGFR—KIT—testicular cancer	4.91e-05	0.00237	CbGpPWpGaD
Pimozide—CALM3—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	4.82e-05	0.00232	CbGpPWpGaD
Pimozide—CALM3—DAP12 interactions—FGFR3—testicular cancer	4.82e-05	0.00232	CbGpPWpGaD
Pimozide—CALM3—Signaling by FGFR in disease—FGFR3—testicular cancer	4.82e-05	0.00232	CbGpPWpGaD
Pimozide—CALM3—Signaling by EGFR—FGFR3—testicular cancer	4.77e-05	0.0023	CbGpPWpGaD
Pimozide—CALM3—Downstream signal transduction—KIT—testicular cancer	4.77e-05	0.0023	CbGpPWpGaD
Pimozide—CALM3—Signaling by FGFR—KIT—testicular cancer	4.75e-05	0.00229	CbGpPWpGaD
Pimozide—CALM3—Signaling by EGFR in Cancer—FGFR3—testicular cancer	4.73e-05	0.00228	CbGpPWpGaD
Pimozide—CALM3—Signaling by ERBB2—KIT—testicular cancer	4.72e-05	0.00228	CbGpPWpGaD
Pimozide—CALM3—Signaling by PDGF—FGFR3—testicular cancer	4.71e-05	0.00227	CbGpPWpGaD
Pimozide—CALM3—DAP12 signaling—KIT—testicular cancer	4.7e-05	0.00227	CbGpPWpGaD
Pimozide—CALM2—Signaling by FGFR in disease—FGFR3—testicular cancer	4.66e-05	0.00225	CbGpPWpGaD
Pimozide—CALM1—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	4.66e-05	0.00225	CbGpPWpGaD
Pimozide—CALM1—DAP12 interactions—FGFR3—testicular cancer	4.66e-05	0.00225	CbGpPWpGaD
Pimozide—CALM1—Signaling by FGFR in disease—FGFR3—testicular cancer	4.66e-05	0.00225	CbGpPWpGaD
Pimozide—CALM2—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	4.66e-05	0.00225	CbGpPWpGaD
Pimozide—CALM2—DAP12 interactions—FGFR3—testicular cancer	4.66e-05	0.00225	CbGpPWpGaD
Pimozide—CALM1—Signaling by EGFR—FGFR3—testicular cancer	4.62e-05	0.00223	CbGpPWpGaD
Pimozide—CALM2—Signaling by EGFR—FGFR3—testicular cancer	4.62e-05	0.00223	CbGpPWpGaD
Pimozide—CALM2—Downstream signal transduction—KIT—testicular cancer	4.62e-05	0.00223	CbGpPWpGaD
Pimozide—CALM1—Downstream signal transduction—KIT—testicular cancer	4.62e-05	0.00223	CbGpPWpGaD
Pimozide—CYP3A4—Biological oxidations—HPGDS—testicular cancer	4.61e-05	0.00222	CbGpPWpGaD
Pimozide—CALM2—Signaling by FGFR—KIT—testicular cancer	4.59e-05	0.00221	CbGpPWpGaD
Pimozide—CALM1—Signaling by FGFR—KIT—testicular cancer	4.59e-05	0.00221	CbGpPWpGaD
Pimozide—CALM2—Signaling by EGFR in Cancer—FGFR3—testicular cancer	4.58e-05	0.00221	CbGpPWpGaD
Pimozide—CALM1—Signaling by EGFR in Cancer—FGFR3—testicular cancer	4.58e-05	0.00221	CbGpPWpGaD
Pimozide—CALM2—Signaling by ERBB2—KIT—testicular cancer	4.57e-05	0.0022	CbGpPWpGaD
Pimozide—CALM1—Signaling by ERBB2—KIT—testicular cancer	4.57e-05	0.0022	CbGpPWpGaD
Pimozide—CALM2—Signaling by PDGF—FGFR3—testicular cancer	4.56e-05	0.0022	CbGpPWpGaD
Pimozide—CALM1—Signaling by PDGF—FGFR3—testicular cancer	4.56e-05	0.0022	CbGpPWpGaD
Pimozide—CALM2—DAP12 signaling—KIT—testicular cancer	4.55e-05	0.00219	CbGpPWpGaD
Pimozide—CALM1—DAP12 signaling—KIT—testicular cancer	4.55e-05	0.00219	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—INSL3—testicular cancer	4.49e-05	0.00217	CbGpPWpGaD
Pimozide—CALM3—B Cell Activation—FGFR3—testicular cancer	4.46e-05	0.00215	CbGpPWpGaD
Pimozide—CALM3—Signaling by FGFR in disease—KIT—testicular cancer	4.42e-05	0.00213	CbGpPWpGaD
Pimozide—CALM3—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	4.42e-05	0.00213	CbGpPWpGaD
Pimozide—CALM3—DAP12 interactions—KIT—testicular cancer	4.42e-05	0.00213	CbGpPWpGaD
Pimozide—CALM3—Signaling by Wnt—H2AFZ—testicular cancer	4.42e-05	0.00213	CbGpPWpGaD
Pimozide—CALM3—Signaling by NGF—KITLG—testicular cancer	4.42e-05	0.00213	CbGpPWpGaD
Pimozide—CALM3—Signaling by EGFR—KIT—testicular cancer	4.38e-05	0.00211	CbGpPWpGaD
Pimozide—CALM3—Signaling by EGFR in Cancer—KIT—testicular cancer	4.34e-05	0.00209	CbGpPWpGaD
Pimozide—CALM3—Signaling by PDGF—KIT—testicular cancer	4.33e-05	0.00209	CbGpPWpGaD
Pimozide—CALM1—B Cell Activation—FGFR3—testicular cancer	4.31e-05	0.00208	CbGpPWpGaD
Pimozide—CALM2—B Cell Activation—FGFR3—testicular cancer	4.31e-05	0.00208	CbGpPWpGaD
Pimozide—CALM1—Signaling by FGFR in disease—KIT—testicular cancer	4.28e-05	0.00206	CbGpPWpGaD
Pimozide—CALM2—Signaling by FGFR in disease—KIT—testicular cancer	4.28e-05	0.00206	CbGpPWpGaD
Pimozide—CALM2—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	4.28e-05	0.00206	CbGpPWpGaD
Pimozide—CALM1—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	4.28e-05	0.00206	CbGpPWpGaD
Pimozide—CALM1—DAP12 interactions—KIT—testicular cancer	4.28e-05	0.00206	CbGpPWpGaD
Pimozide—CALM2—DAP12 interactions—KIT—testicular cancer	4.28e-05	0.00206	CbGpPWpGaD
Pimozide—CALM2—Signaling by Wnt—H2AFZ—testicular cancer	4.28e-05	0.00206	CbGpPWpGaD
Pimozide—CALM1—Signaling by Wnt—H2AFZ—testicular cancer	4.28e-05	0.00206	CbGpPWpGaD
Pimozide—CALM1—Signaling by NGF—KITLG—testicular cancer	4.27e-05	0.00206	CbGpPWpGaD
Pimozide—CALM2—Signaling by NGF—KITLG—testicular cancer	4.27e-05	0.00206	CbGpPWpGaD
Pimozide—CALM3—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	4.27e-05	0.00206	CbGpPWpGaD
Pimozide—CALM2—Signaling by EGFR—KIT—testicular cancer	4.24e-05	0.00204	CbGpPWpGaD
Pimozide—CALM1—Signaling by EGFR—KIT—testicular cancer	4.24e-05	0.00204	CbGpPWpGaD
Pimozide—CALM2—Signaling by EGFR in Cancer—KIT—testicular cancer	4.2e-05	0.00203	CbGpPWpGaD
Pimozide—CALM1—Signaling by EGFR in Cancer—KIT—testicular cancer	4.2e-05	0.00203	CbGpPWpGaD
Pimozide—CALM2—Signaling by PDGF—KIT—testicular cancer	4.18e-05	0.00202	CbGpPWpGaD
Pimozide—CALM1—Signaling by PDGF—KIT—testicular cancer	4.18e-05	0.00202	CbGpPWpGaD
Pimozide—CALM3—Innate Immune System—BCL10—testicular cancer	4.18e-05	0.00201	CbGpPWpGaD
Pimozide—CALM2—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	4.13e-05	0.00199	CbGpPWpGaD
Pimozide—CALM1—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	4.13e-05	0.00199	CbGpPWpGaD
Pimozide—CALM3—B Cell Activation—KIT—testicular cancer	4.09e-05	0.00197	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—BCL10—testicular cancer	4.04e-05	0.00195	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—BCL10—testicular cancer	4.04e-05	0.00195	CbGpPWpGaD
Pimozide—CALM3—Adaptive Immune System—BCL10—testicular cancer	4.01e-05	0.00193	CbGpPWpGaD
Pimozide—CALM2—B Cell Activation—KIT—testicular cancer	3.96e-05	0.00191	CbGpPWpGaD
Pimozide—CALM1—B Cell Activation—KIT—testicular cancer	3.96e-05	0.00191	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—INSL3—testicular cancer	3.94e-05	0.0019	CbGpPWpGaD
Pimozide—CALM3—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	3.92e-05	0.00189	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—BCL10—testicular cancer	3.88e-05	0.00187	CbGpPWpGaD
Pimozide—CALM2—Adaptive Immune System—BCL10—testicular cancer	3.88e-05	0.00187	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—INSL3—testicular cancer	3.88e-05	0.00187	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—INSL3—testicular cancer	3.87e-05	0.00187	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—INSL3—testicular cancer	3.81e-05	0.00184	CbGpPWpGaD
Pimozide—CALM2—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	3.79e-05	0.00183	CbGpPWpGaD
Pimozide—CALM1—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	3.79e-05	0.00183	CbGpPWpGaD
Pimozide—CALM3—Signaling by NGF—FGFR3—testicular cancer	3.28e-05	0.00158	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—INSL3—testicular cancer	3.22e-05	0.00155	CbGpPWpGaD
Pimozide—CALM2—Signaling by NGF—FGFR3—testicular cancer	3.17e-05	0.00153	CbGpPWpGaD
Pimozide—CALM1—Signaling by NGF—FGFR3—testicular cancer	3.17e-05	0.00153	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—INSL3—testicular cancer	3.12e-05	0.0015	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—INSL3—testicular cancer	3.12e-05	0.0015	CbGpPWpGaD
Pimozide—CALM3—Signaling by NGF—KIT—testicular cancer	3.01e-05	0.00145	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	2.94e-05	0.00142	CbGpPWpGaD
Pimozide—CALM2—Signaling by NGF—KIT—testicular cancer	2.91e-05	0.00141	CbGpPWpGaD
Pimozide—CALM1—Signaling by NGF—KIT—testicular cancer	2.91e-05	0.00141	CbGpPWpGaD
Pimozide—CALM3—Innate Immune System—KITLG—testicular cancer	2.52e-05	0.00121	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—KITLG—testicular cancer	2.44e-05	0.00117	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—KITLG—testicular cancer	2.44e-05	0.00117	CbGpPWpGaD
Pimozide—CALM3—Immune System—BCL10—testicular cancer	2.43e-05	0.00117	CbGpPWpGaD
Pimozide—CALM3—Adaptive Immune System—KITLG—testicular cancer	2.42e-05	0.00117	CbGpPWpGaD
Pimozide—CALM2—Immune System—BCL10—testicular cancer	2.35e-05	0.00113	CbGpPWpGaD
Pimozide—CALM1—Immune System—BCL10—testicular cancer	2.35e-05	0.00113	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—HPGDS—testicular cancer	2.34e-05	0.00113	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—KITLG—testicular cancer	2.34e-05	0.00113	CbGpPWpGaD
Pimozide—CALM2—Adaptive Immune System—KITLG—testicular cancer	2.34e-05	0.00113	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	2.29e-05	0.00111	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—H2AFZ—testicular cancer	1.97e-05	0.00095	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—STK11—testicular cancer	1.96e-05	0.000945	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—H2AFZ—testicular cancer	1.94e-05	0.000936	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—STK11—testicular cancer	1.93e-05	0.000931	CbGpPWpGaD
Pimozide—CALM3—Innate Immune System—FGFR3—testicular cancer	1.87e-05	0.000902	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—KITLG—testicular cancer	1.81e-05	0.000874	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—FGFR3—testicular cancer	1.81e-05	0.000873	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—FGFR3—testicular cancer	1.81e-05	0.000873	CbGpPWpGaD
Pimozide—CALM3—Adaptive Immune System—FGFR3—testicular cancer	1.8e-05	0.000867	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—KITLG—testicular cancer	1.79e-05	0.000861	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—FGFR3—testicular cancer	1.74e-05	0.000838	CbGpPWpGaD
Pimozide—CALM2—Adaptive Immune System—FGFR3—testicular cancer	1.74e-05	0.000838	CbGpPWpGaD
Pimozide—CALM3—Innate Immune System—KIT—testicular cancer	1.72e-05	0.000829	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—STK11—testicular cancer	1.7e-05	0.000821	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—HPGDS—testicular cancer	1.7e-05	0.000819	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—HPGDS—testicular cancer	1.69e-05	0.000817	CbGpPWpGaD
Pimozide—CALM3—Metabolism—HPGDS—testicular cancer	1.69e-05	0.000813	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—H2AFZ—testicular cancer	1.67e-05	0.000803	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—KIT—testicular cancer	1.66e-05	0.000802	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—KIT—testicular cancer	1.66e-05	0.000802	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—STK11—testicular cancer	1.66e-05	0.000798	CbGpPWpGaD
Pimozide—CALM3—Adaptive Immune System—KIT—testicular cancer	1.65e-05	0.000796	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—H2AFZ—testicular cancer	1.65e-05	0.000795	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—STK11—testicular cancer	1.64e-05	0.000791	CbGpPWpGaD
Pimozide—CALM2—Metabolism—HPGDS—testicular cancer	1.63e-05	0.000787	CbGpPWpGaD
Pimozide—CALM1—Metabolism—HPGDS—testicular cancer	1.63e-05	0.000787	CbGpPWpGaD
Pimozide—CALM2—Adaptive Immune System—KIT—testicular cancer	1.6e-05	0.00077	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—KIT—testicular cancer	1.6e-05	0.00077	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—KITLG—testicular cancer	1.53e-05	0.000739	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—KITLG—testicular cancer	1.52e-05	0.000732	CbGpPWpGaD
Pimozide—CALM3—Disease—H2AFZ—testicular cancer	1.47e-05	0.00071	CbGpPWpGaD
Pimozide—CALM3—Immune System—KITLG—testicular cancer	1.47e-05	0.000707	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—H2AFZ—testicular cancer	1.44e-05	0.000693	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—STK11—testicular cancer	1.43e-05	0.000689	CbGpPWpGaD
Pimozide—CALM2—Disease—H2AFZ—testicular cancer	1.42e-05	0.000687	CbGpPWpGaD
Pimozide—CALM1—Disease—H2AFZ—testicular cancer	1.42e-05	0.000687	CbGpPWpGaD
Pimozide—CALM2—Immune System—KITLG—testicular cancer	1.42e-05	0.000684	CbGpPWpGaD
Pimozide—CALM1—Immune System—KITLG—testicular cancer	1.42e-05	0.000684	CbGpPWpGaD
Pimozide—CALM3—Disease—KITLG—testicular cancer	1.35e-05	0.000653	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—FGFR3—testicular cancer	1.35e-05	0.00065	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—FGFR3—testicular cancer	1.33e-05	0.00064	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—KITLG—testicular cancer	1.32e-05	0.000638	CbGpPWpGaD
Pimozide—CALM2—Disease—KITLG—testicular cancer	1.31e-05	0.000632	CbGpPWpGaD
Pimozide—CALM1—Disease—KITLG—testicular cancer	1.31e-05	0.000632	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—HPGDS—testicular cancer	1.31e-05	0.000632	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—HPGDS—testicular cancer	1.28e-05	0.000616	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—H2AFZ—testicular cancer	1.26e-05	0.000609	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—STK11—testicular cancer	1.25e-05	0.000605	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—H2AFZ—testicular cancer	1.24e-05	0.000599	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—H2AFZ—testicular cancer	1.24e-05	0.000597	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—KIT—testicular cancer	1.24e-05	0.000596	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—STK11—testicular cancer	1.23e-05	0.000595	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—STK11—testicular cancer	1.23e-05	0.000595	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—STK11—testicular cancer	1.23e-05	0.000594	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—STK11—testicular cancer	1.23e-05	0.000594	CbGpPWpGaD
Pimozide—CALM3—Metabolism—STK11—testicular cancer	1.23e-05	0.000591	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—H2AFZ—testicular cancer	1.22e-05	0.000588	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—KIT—testicular cancer	1.22e-05	0.000588	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—STK11—testicular cancer	1.21e-05	0.000585	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—HPGDS—testicular cancer	1.2e-05	0.000581	CbGpPWpGaD
Pimozide—CALM2—Metabolism—STK11—testicular cancer	1.19e-05	0.000572	CbGpPWpGaD
Pimozide—CALM1—Metabolism—STK11—testicular cancer	1.19e-05	0.000572	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—KITLG—testicular cancer	1.16e-05	0.00056	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—KITLG—testicular cancer	1.14e-05	0.000551	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—KITLG—testicular cancer	1.14e-05	0.00055	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—FGFR3—testicular cancer	1.14e-05	0.000549	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—FGFR3—testicular cancer	1.13e-05	0.000544	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—KITLG—testicular cancer	1.12e-05	0.000541	CbGpPWpGaD
Pimozide—CALM3—Immune System—FGFR3—testicular cancer	1.09e-05	0.000526	CbGpPWpGaD
Pimozide—CALM1—Immune System—FGFR3—testicular cancer	1.05e-05	0.000508	CbGpPWpGaD
Pimozide—CALM2—Immune System—FGFR3—testicular cancer	1.05e-05	0.000508	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—KIT—testicular cancer	1.05e-05	0.000504	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—KIT—testicular cancer	1.04e-05	0.000499	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—H2AFZ—testicular cancer	1.03e-05	0.000497	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—STK11—testicular cancer	1.02e-05	0.000494	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—HPGDS—testicular cancer	1.02e-05	0.000492	CbGpPWpGaD
Pimozide—CALM3—Disease—FGFR3—testicular cancer	1.01e-05	0.000485	CbGpPWpGaD
Pimozide—CALM3—Immune System—KIT—testicular cancer	1e-05	0.000483	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—H2AFZ—testicular cancer	9.97e-06	0.000481	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—H2AFZ—testicular cancer	9.97e-06	0.000481	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—STK11—testicular cancer	9.91e-06	0.000478	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—STK11—testicular cancer	9.91e-06	0.000478	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—FGFR3—testicular cancer	9.83e-06	0.000474	CbGpPWpGaD
Pimozide—CALM2—Disease—FGFR3—testicular cancer	9.74e-06	0.000469	CbGpPWpGaD
Pimozide—CALM1—Disease—FGFR3—testicular cancer	9.74e-06	0.000469	CbGpPWpGaD
Pimozide—CALM1—Immune System—KIT—testicular cancer	9.68e-06	0.000467	CbGpPWpGaD
Pimozide—CALM2—Immune System—KIT—testicular cancer	9.68e-06	0.000467	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—STK11—testicular cancer	9.52e-06	0.000459	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—KITLG—testicular cancer	9.48e-06	0.000457	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—STK11—testicular cancer	9.29e-06	0.000448	CbGpPWpGaD
Pimozide—CALM3—Disease—KIT—testicular cancer	9.24e-06	0.000446	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—KITLG—testicular cancer	9.17e-06	0.000442	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—KITLG—testicular cancer	9.17e-06	0.000442	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—KIT—testicular cancer	9.02e-06	0.000435	CbGpPWpGaD
Pimozide—CALM2—Disease—KIT—testicular cancer	8.94e-06	0.000431	CbGpPWpGaD
Pimozide—CALM1—Disease—KIT—testicular cancer	8.94e-06	0.000431	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—STK11—testicular cancer	8.75e-06	0.000422	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—FGFR3—testicular cancer	8.63e-06	0.000416	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—FGFR3—testicular cancer	8.49e-06	0.000409	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—FGFR3—testicular cancer	8.47e-06	0.000409	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—FGFR3—testicular cancer	8.34e-06	0.000402	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—KIT—testicular cancer	7.92e-06	0.000382	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—HPGDS—testicular cancer	7.88e-06	0.00038	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—KIT—testicular cancer	7.8e-06	0.000376	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—KIT—testicular cancer	7.78e-06	0.000375	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—KIT—testicular cancer	7.65e-06	0.000369	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—STK11—testicular cancer	7.42e-06	0.000358	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—FGFR3—testicular cancer	7.05e-06	0.00034	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—FGFR3—testicular cancer	6.82e-06	0.000329	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—FGFR3—testicular cancer	6.82e-06	0.000329	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—KIT—testicular cancer	6.47e-06	0.000312	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—KIT—testicular cancer	6.26e-06	0.000302	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—KIT—testicular cancer	6.26e-06	0.000302	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—STK11—testicular cancer	5.72e-06	0.000276	CbGpPWpGaD
